Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process

NeuroToxicology

Volumn 25, Issue 4 SPEC. ISS., 2004, Pages 555-572

  Bowyer, John F ^a   Harris, Angela J ^a   Delongchamp, Robert R ^a   Jakab, Robert L ^a   Miller, Diane B ^b   Little, A Roger ^b   O'Callaghan, James P ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Amphetamine; Gene expression; Neurodegeneration

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; LIPOCORTIN 5; MESSENGER RNA; NEUROPEPTIDE Y; PROTEIN PRECURSOR; SOMATOMEDIN BINDING PROTEIN 1;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DNA MICROARRAY; DOPAMINE METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; MALE; NEUROTOXICITY; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRIFORM CORTEX; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TOXICITY TESTING; TOXICOKINETICS;

EID: 2942571273     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2003.08.005     Document Type: Conference Paper

References (70)

1. Backman C., Morales M. Acute methamphetamine administration upregulates NGFI-B mRNA expression in the striatum. Synapse. 44:2002;158-165
2. Bates S., Read S.J., Harrison D.C., Topp S., Morrow R., Gale D., Murdock P., Barone F.C., Parsons A.A., Gloger I.S. Characterization of gene expression changes following permanent MCAO in the rat using subtractive hybridization. Mol. Brain Res. 293:2001;70-80
3. Benjamini Y., Hochberg Y. On the adaptive control of the false discovery rate in multiple testing with independent statistics. J. Educ. Behav. Stat. 25:2000;60-83
4. Bowyer J.F. Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or D-amphetamine. Brain Res. 885:2000;166-171
5. Bowyer JF, Holson RR. Methamphetamine and amphetamine neurotoxicity: characteristics, interactions with body temperature and possible mechanisms. In: Chang LW, Dyer RS, editors. Handbook of neurotoxicology, vol. II. New York, Basel, Hong Kong: Marcel Dekker Inc.; 1995. p. 845-70.
6. Bowyer J.F., Tank A.W., Newport G.D., Slikker W. Jr., Ali S.F., Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260:1992;817-824
7. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268:1994;1571-1580
8. Bowyer J.F., Peterson S.L., Rountree R.L., Tor-Agbidye J., Wang G.J. Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res. 809:1998;77-90
9. Bowyer J.F., Holson R.R., Miller D.B., O'Callaghan J.P. Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation. Brain Res. 919:2001;179-183
10. Cadet J.L., Jayanthi S., McCoy M.T., Vawter M., Ladenheim B. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse. 41:2001;40-48
11. Chen J., Sochivko D., Beck H., Marechal D., Wiestler O.D., Becker A.J. Activity-induced expression of common reference genes in individual CNS neurons. Lab. Invest. 81:2001;913-916
12. Cheung R.T., Cechetto D.F. Neuropeptide changes following excitotoxic lesion of the insular cortex in rats. J. Comp. Neurol. 362:1995;535-550
13. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 15:1993;532-537
14. Chomczynski P. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques. 19:1995;532-537
15. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. 36:2001;1-22
16. Delongchamp R.R., Harris A.J., Bowyer J.F. A statistical approach in using cDNA array analysis to find modest, 2-fold or less, changes in gene expression in several brain regions after neurotoxic insult. Ann. N.Y. Acad. Sci. 993:2003;363-376
17. Deng X., Wang Y., Chou J., Cadet J.L. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. 93:2001;64-69
18. Eisch A.J., Marshall J.F. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse. 30:1998;433-445
19. Eisch A.J., O'Dell S.J., Marshall J.F. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse. 22:1996;217-225
20. Eisch A.J., Schmued L.C., Marshall J.F. Characterizing cortical neuron injury with Flouro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse. 30:1998;329-333
21. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse. Neurology. 54:2000;1344-1349
22. Freeman W.M., Robertson D.J., Vrana K.E. Fundamentals of DNA hybridization arrays for gene expression analysis. Biotechniques. 29:2000;1042-1046
23. Freeman W.M., Brebner K., Lynch W.J., Robertson D.J., Roberts D.C., Vrana K.E. Cocaine-responsive gene expression changes in rat hippocampus. Neurosciences. 108:2001a;371-380
24. Freeman W.M., Nader M.A., Nader S.H., Robertson D.J., Gioia L., Mitchell S.M., Daunais J.B., Porrino L.J., Friedman D.P., Vrana K.E. Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. J. Neurochem. 77:2001b;542-549
25. Gall C.M. Seizure-induced changes in neurotrophin expression: implications for epilepsy. Exp. Neurol. 124:1993;150-166
26. Goto S., Korematsu K., Oyama T., Yamada K., Hamada J., Inoue N., Nagahiro S., Ushio Y. Neuronal induction of 72-kDa heat shock protein following methamphetamine-induced hyperthermia in the mouse hippocampus. Brain Res. 626:1993;351-356
27. Jakab R.L., Bowyer J.F. Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke. Brain Res. 958:2002;52-69
28. Jayanthi S., Deng X., Bordelon M., McCoy M.T., Cadet J.L. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J. 15:2002;1745-1752
29. Kiessling M., Gass P. Immediate early gene expression in experimental epilepsy. Brain Pathol. 3:1993;381-393
30. Kodama M., Akiyama K., Ujike H., Shimizu Y., Tanaka Y., Kuroda S. A robust increase in expression of Arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration. Brain Res. 796:1998;273-283
31. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9:1997;482-497
32. Kopp J., Nanobashvili A., Kokaia Z., Lindvall O., Hokfelt T. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Brain Res. Mol. Brain Res. 72:1999;17-29
33. Lee M.L.T., Kuo F.C., Whitmore G.A., Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. PNAS. 97:2000;9834-9839
34. Letchworth S.R., Sexton T., Childers S.R., Vrana K.E., Vaughan R.A., Davies H.M., Porrino L.J. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration. J. Neurochem. 73:1999;1982-1989
35. Lindefors N., Brene S., Herrera-Marschitz M., Persson H. Regulation of neuropeptide Y gene expression in rat brain. Ann. N.Y. Acad. Sci. 611:1990;175-185
36. Lu W., Wolf W.E. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Mol. Brain Res. 49:1997;137-148
37. 11C ]WIN-35, 428 J. Neurosci. 18:1998;8417-8422
38. Miki N. Gene expression by addictive drugs and drug dependence. Nihon Shinkei seishin Yakurigaku Zasshi. 2:2001;127-131
39. Miller D.B., O'Callaghan J.P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;752-760
40. Mirnics K. Microarrays in brain research: the good, the bad and the ugly. Nature Rev. Neurosci. 2:2001;444-447
41. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2001;53-67
42. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63
43. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif/268 in rat striatum after halopewridol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4270-4274
44. Nowak T.S. Effects of amphetamine on protein synthesis and energy metabolism in mouse brain: role of drug-induced hyperthermia. J. Neurochem. 50:1988;285-294
45. O'Callaghan J.P. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13:1991;275-281
46. O'Callaghan JP. Measurement of glial fibrillary acidic protein. In: Costa LG, editor. Current protocols in toxicology. New York: Wiley; 2002. p. 12.81.1-.2.
47. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751
48. O'Callaghan JP, Miller DB. Neurotoxic effects of substituted amphetamines in rats and mice. In: Massaro EJ, editor. Handbook of neurotoxicology, vol. 2. Totowa, NJ: Humana Press Inc.; 2001. p. 269-301.
49. O'Dell S.J., Marshall J.F. Effects of vibrissae removal on methamphetamine-induced damage to rat somatosensory cortical neurons. Synapse. 43:2002;122-130
50. Paxinos G, Watson C. The rat brain in stereotaxic coordinatesm, vol. 2. San Diego, CA: Academic Press; 1995.
51. Reinhard J.F. Jr., O'Callaghan J.P. Measurement of tyrosine hydroxylase apoenzyme protein by enzyme-linked immunosorbent assay (ELISA): effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity and content. Anal. Biochem. 196:1991;296-301
52. Reutelingsperger C.P., Dumont E., Thimister P.W., van Genderen H., Kenis H., van de Eijnde S., Heidendal G., Hofstra L. Visualization of cell death in vivo with annexin A5 imaging protocol. J. Immunol. Meth. 265:2002;123-132
53. Schmued L.C., Bowyer J.F. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759:1997;135-140
54. Schweder T., Spjotvoll E. Plots of P-values to evaluate many tests simultaneously. Biometrika. 69:1982;493-502
55. Seiden LS, Sabol KE. Neurotoxicity of methamphetamine-related drugs and cocaine. In: Chang LW, Dyer RS, editors. Handbook of neurotoxicology, vol. 2. New York, Basel, Hong Kong: Marcel Dekker, Inc.; 1995. p. 824-44.
56. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85
57. Sokolov B.P., Polesskaya O.O., Uhl G.R. Mouse brain gene expression changes after acute and chronic amphetamine. J. Neurochem. 84:2003;244-252
58. Sonsalla P.K., Nicklas W.J., Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science. 243:1989;398-400
59. Stephans S.E., Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse. 17:1994;203-209
60. Storey J.A. A direct approach to false discovery rates. J. R. Stat. Soc. B. 64:2002;479-498
61. Tang Y., Lu A., Aronow B.J., Sharp F.R. Blood genomic responses differ after stroke, seizures, hypoglycemia and hypoxia: blood genomic fingerprints of disease. Ann. Neurol. 50:2001;699-707
62. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Logan J., Wong C., Miller E.N. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry. 158:2001a;377-382
63. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Wong C., Logan J. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am. J. Psychiatry. 158:2001b;383-389
64. Wagner G.C., Ricaurte G.A., Johanson C.E., Schuster C.R., Seiden L.S. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in the caudate. Neurology. 30:1980;547-550
65. Wang J.Q., Daunias J.B., McGinty J.F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 18:1994;343-353
66. Wang Y., Gupta A., Toledo-Rodriguez M., Wu C.Z., Markram H. Anatomical, physiological, molecular and circuit properties of nest basket cells in the developing somatosensory cortex. Cereb Cortex. 12:2002;395-410
67. Westwood W.C., Hanson G.R. Effects of stimulants of abuse on the extrapyramidal and limbic neuropeptide Y systems. J. Pharmacol. Exp. Ther. 288:1999;1160-1168
68. Westman J., Sharma H.S. Heat shock protein response in the central nervous system following hyperthermia. Prog. Brain Res. 115:1998;207-239
69. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med. 2:1996;699-703
70. Xie T., Tong L., Barrett T., Yuan J., Hatzidimitriou G., McCann U.D., Becker K.G., Donovan D.M., Ricaurte G.A. Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci. 22:2002;274-283